Literature DB >> 32348522

An update on the epidemiology of ANCA-associated vasculitis.

Aladdin J Mohammad1,2.   

Abstract

ANCA-associated vasculitis (AAV) includes granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis. Epidemiological studies in AAV are important in understanding possible aetiologic mechanisms and facilitating healthcare planning. However, epidemiological studies present a number of challenges including clear definition of cases differentiated from other clinical disorders, and identification of cases due to the rarity of AAV. The aim of this review is to summarize different aspects on the epidemiology of ANCA-associated vasculitis from different geographical areas throughout the world. During the past three decades, development of classification criteria worldwide, including the ACR classification of 1990, the Chapel Hill consensus definitions updated in 2012 and the EMA algorithm has facilitated epidemiology studies in AAV. The available epidemiological studies reported in AAV suggest that incidence and prevalence may have increased over the past 30 years. Possible explanations for this increase may be a genuine increase in incidence, the evolution of classification criteria and the definition, and availability and wider use of ANCA serology to aid diagnosis, and greater physician awareness through education. The age-specific incidence for the whole group of AAV showed a clear increase with age. However, there has been a clear shift in the peak age at onset towards a higher age during the last 20-30 years. In addition, variation in incidence of AAV between men and women has been clearly evident in a number of epidemiological studies.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ANCA; epidemiology; vasculitis

Year:  2020        PMID: 32348522     DOI: 10.1093/rheumatology/keaa089

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

1.  Increased circulating PD-1hiCXCR5- peripheral T helper cells are associated with disease activity of ANCA-associated vasculitis.

Authors:  Zhenyu Liu; Xueqin Li; Ningning Fan; Hong Wang; Wenli Xia; Wenjie Li; Sha Tang; Xinyuan Zhou; Yuzhang Wu; Liyun Zou; Jingyi Li; Jingbo Zhang
Journal:  Clin Exp Immunol       Date:  2022-05-12       Impact factor: 4.330

Review 2.  [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].

Authors:  Sabrina Arnold; Sebastian Klapa; Konstanze Holl-Ulrich; Antje Müller; Anja Kerstein-Stähle; Peter Lamprecht
Journal:  Z Rheumatol       Date:  2022-08-12       Impact factor: 1.530

3.  Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients.

Authors:  Ebru Dirikgil; Sander W Tas; Cornelis A Verburgh; Darius Soonawala; A Elisabeth Hak; Hilde H F Remmelts; Daphne IJpelaar; Gozewijn D Laverman; Abraham Rutgers; Jaap M van Laar; Hein J Bernelot Moens; Peter M J Verhoeven; Ton J Rabelink; Willem Jan W Bos; Y K Onno Teng
Journal:  Rheumatol Adv Pract       Date:  2022-06-09

4.  A Surgical Presentation of Churg-Strauss Syndrome.

Authors:  Nikhil Vasandani; Martha Isaac; Amrit Bajwa; Margaret Sheehan; Emmeline Nugent
Journal:  Cureus       Date:  2022-04-21

5.  A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination.

Authors:  Beop Chang Kim; Han Seong Kim; Kum Hyun Han; Sang Youb Han; Hyung Ah Jo
Journal:  J Korean Med Sci       Date:  2022-07-04       Impact factor: 5.354

Review 6.  Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies.

Authors:  Adél Molnár; Péter Studinger; Nóra Ledó
Journal:  Front Med (Lausanne)       Date:  2022-06-03

7.  Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Sara Thietart; Alexandre Karras; Jean-François Augusto; Carole Philipponnet; Pierre-Louis Carron; Xavier Delbrel; Rafik Mesbah; Gilles Blaison; Pierre Duffau; Khalil El Karoui; Perrine Smets; Jonathan London; Luc Mouthon; Loïc Guillevin; Benjamin Terrier; Xavier Puéchal
Journal:  JAMA Netw Open       Date:  2022-07-01

8.  Increased Circulating PD-1 hi CXCR5 - Peripheral T Helper Cells are Associated with Disease Activity of ANCA-Associated Vasculitis.

Authors:  Zhenyu Liu; Xueqin Li; Ningning Fan; Hong Wang; Wenli Xia; Wenjie Li; Sha Tang; Xinyuan Zhou; Yuzhang Wu; Liyun Zou; Jingyi Li; Jingbo Zhang
Journal:  Clin Exp Immunol       Date:  2022-01-12       Impact factor: 5.732

9.  Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly.

Authors:  Adél Molnár; Mbuotidem Jeremiah Thomas; Attila Fintha; Magdolna Kardos; Deján Dobi; András Tislér; Nóra Ledó
Journal:  Sci Rep       Date:  2021-12-29       Impact factor: 4.379

10.  Utility of anti-neutrophil cytoplasmic antibody screening in idiopathic interstitial lung disease.

Authors:  Lee M Fidler; Sonja Kandel; Jolene H Fisher; Shikha Mittoo; Shane Shapera
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-06-28       Impact factor: 0.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.